Keurig Dr Pepper Reports Full Year 2021 Results and Successful Delivery of Three-Year Merger Commitments
Keurig Dr Pepper Inc. (KDP) reported robust financial results for Q4 and FY 2021, showing net sales growth of 8.7% to $3.39 billion in Q4 and 9.2% to $12.68 billion for the full year. Adjusted diluted EPS rose by 15.4% in Q4 to $0.45, while full-year adjusted diluted EPS increased 14.3% to $1.60. The company successfully added nearly 3 million new households to its Keurig system, driving significant market share gains. Despite challenges from inflation and supply chain disruptions, KDP's operational leverage improved, with a management leverage ratio of 2.9x by year-end 2021.
- Net sales grew 9.2% year-over-year to $12.68 billion for FY 2021.
- Adjusted diluted EPS increased 14.3% to $1.60 for FY 2021.
- Added nearly 3 million new households to Keurig system, reaching almost 36 million total.
- Improved management leverage ratio to 2.9x, down from 3.6x in 2020.
- Strong retail dollar consumption growth of 12.6% across cold beverage retail base in Q4.
- Inflation and supply chain disruptions led to increased operating costs.
- GAAP operating income decreased 15.5% in Q4 due to inflationary pressures.
- Adjusted operating income margin decreased from 27.5% to 26.8% in Q4.
BURLINGTON, Mass. and FRISCO, Texas, Feb. 24, 2022 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) today reported strong financial results for the fourth quarter and full year ended December 31, 2021 and affirms guidance for 2022.
Reported GAAP Basis | Adjusted Basis1 | |||
Q4 | FY 2021 | Q4 | FY 2021 | |
Net Sales % vs Prior Year % vs Prior Year – Constant Currency % vs FY 2019 – Constant Currency |
|
| ||
Diluted EPS % vs Prior Year % vs FY 2019 |
Full-year 2021 highlights
Strong performance in 2021 marked the successful completion of the Company's three-year merger period, with results that met or exceeded all key commitments. Highlights of 2021 performance include:
- Posted high single-digit net sales growth and double-digit Adjusted diluted EPS growth.
- Grew market share2 in nearly
75% of the Company's cold beverage retail base. - Added nearly three million new U.S. households to the Keurig system, bringing total Keurig households to almost 36 million, reflecting successful brewer innovation including the Keurig Supreme Plus Smart – KDP's first connected brewer launch.
- Improved KDP's management leverage ratio to 2.9x at year-end 2021.
- Continued to navigate the evolving macro challenges presented by COVID-19 and prioritize and invest in the health and safety of employees.
- Advanced KDP's corporate responsibility agenda, including adding new goals for Diversity & Inclusion, Positive Hydration, and Regenerative Agriculture.
Commenting on the announcement, Chairman and CEO Bob Gamgort stated, "We finished 2021 with exceptional top-line momentum, driven by robust consumer demand across our portfolio, and our third consecutive year of double-digit Adjusted EPS growth. Despite ongoing macro and COVID-related challenges, we successfully delivered our merger commitments on or ahead of the targets we set four years ago. We head into 2022 with confidence in the stronger, faster-growing business we have built, poised to continue to drive outsized long-term value creation in an environment that we expect to remain challenging for some time."
2021 Full Year Consolidated Results
Net sales for the full year of 2021 increased
KDP in-market performance in the Liquid Refreshment Beverages (LRB) category remained strong for the year, with retail dollar consumption2 advancing
In coffee, retail dollar consumption of single-serve pods manufactured by KDP in IRi tracked channels grew
GAAP operating income for the full year of 2021 increased
Adjusted operating income for the full year of 2021 increased
GAAP net income for the full year of 2021 advanced
Adjusted net income for the full year of 2021 increased
KDP generated exceptionally strong free cash flow totaling
1 Adjusted financial metrics used in this release are non-GAAP. See reconciliations of GAAP results to Adjusted results in the accompanying tables.
2 Market share and retail consumption data based on Keurig Dr Pepper's custom IRi category definitions for the 13-week and 52-week periods ending 12/26/2021.
3 CSDs refer to "Carbonated Soft Drinks".
2021 Full Year Segment Results
Coffee Systems
Net sales for the full year of 2021 increased
The volume/mix growth of
GAAP operating income increased
Adjusted operating income totaled
Packaged Beverages
Net sales for the full year of 2021 increased
Driving the strong net sales performance were Canada Dry, Sunkist, Dr Pepper, A&W, 7UP and Squirt CSDs, as well as growth in Mott's, Polar seltzers, Vita Coco, and Snapple, partially offset by a decline in Hawaiian Punch.
GAAP operating income increased
Adjusted operating income increased
Beverage Concentrates
Net sales for the full year of 2021 increased
Total shipment volume increased
GAAP operating income for the full year increased
Adjusted operating income increased
Latin America Beverages
Net sales for the full year of 2021 increased
GAAP operating income for the full year increased
Adjusted operating income increased
Fourth Quarter Consolidated Results
Net sales for the fourth quarter of 2021 increased
KDP in-market performance in the LRB category remained strong in the quarter, with retail dollar consumption advancing
In coffee, retail dollar consumption of single-serve pods manufactured by KDP in IRi tracked channels increased
GAAP operating income increased
Adjusted operating income in the quarter grew
GAAP net income in the fourth quarter of 2021 increased
Adjusted net income advanced
Fourth Quarter Segment Results
Coffee Systems
Net sales for the fourth quarter of 2021 totaled
The volume/mix increase of
GAAP operating income declined
Adjusted operating income declined
Packaged Beverages
Net sales for the fourth quarter of 2021 increased
Leading the net sales performance were Canada Dry, Dr Pepper, Sunkist, A&W, 7UP and Squirt CSDs, Mott's, and Snapple, as well as growth in Polar seltzers, CORE Hydration, Vita Coco, Clamato, Yoo-Hoo, and Bai.
GAAP operating income increased
Adjusted operating income increased
Beverage Concentrates
Net sales for the fourth quarter of 2021 increased
Total shipment volume versus year-ago decreased
GAAP operating income in the fourth quarter of 2021 increased
Adjusted operating income increased
Latin America Beverages
Net sales for the fourth quarter of 2021 increased
GAAP operating income in the fourth quarter of 2021 increased
Adjusted operating income increased
KDP 2022 Guidance
KDP affirmed guidance for both net sales and Adjusted diluted EPS growth in 2022 in the mid-single-digit range. The Company expects EPS performance versus 2021 to strengthen throughout the year, with Adjusted diluted EPS growth reaching the high-single-digit range in the second half of 2022, in line with the Company's long-term algorithm.
Investor Contacts:
Steve Alexander
T: 972-673-6769 / steve.alexander@kdrp.com
Media Contact:
Katie Gilroy
T: 781-418-3345 / katie.gilroy@kdrp.com
About Keurig Dr Pepper
Keurig Dr Pepper (KDP) is a leading beverage company in North America, with annual revenue in excess of
FORWARD LOOKING STATEMENTS
Certain statements contained herein are "forward-looking statements" within the meaning of applicable securities laws and regulations. These forward-looking statements can generally be identified by the use of words such as "outlook," "guidance," "anticipate," "expect," "believe," "could," "estimate," "feel," "forecast," "intend," "may," "plan," "potential," "project," "should," "target," "will," "would," and similar words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. These statements are based on the current expectations of our management, are not predictions of actual performance, and actual results may differ materially.
Forward-looking statements are subject to a number of risks and uncertainties, including the impact of the global COVID-19 pandemic and the factors disclosed in our Annual Report on Form 10-K and subsequent filings with the SEC. We are under no obligation to update, modify or withdraw any forward-looking statements, except as required by applicable law.
NON-GAAP FINANCIAL MEASURES
This release includes certain non-GAAP financial measures including Adjusted operating income, Adjusted net income, Adjusted diluted EPS, free cash flow and financial measures presented on a constant currency basis, which differ from results using U.S. Generally Accepted Accounting Principles (GAAP). These non-GAAP financial measures should be considered as supplements to the GAAP reported measures, should not be considered replacements for, or superior to, the GAAP measures and may not be comparable to similarly named measures used by other companies. Non-GAAP financial measures typically exclude certain charges, including one-time costs that are not expected to occur routinely in future periods. The Company uses non-GAAP financial measures internally to focus management on performance excluding these special charges to gauge our business operating performance. Management believes this information is helpful to investors because it increases transparency and assists investors in understanding the underlying performance of the Company and in the analysis of ongoing operating trends. Additionally, management believes that non-GAAP financial measures are frequently used by analysts and investors in their evaluation of companies, and their continued inclusion provides consistency in financial reporting and enables analysts and investors to perform meaningful comparisons of past, present and future operating results. The most directly comparable GAAP financial measures and reconciliations to non-GAAP financial measures are set forth in the appendix to this release and included in the Company's filings with the SEC.
To the extent that the Company provides guidance, it does so only on a non-GAAP basis and does not provide reconciliations of such forward-looking non-GAAP measures to GAAP due to the inability to predict the amount and timing of impacts outside of the Company's control on certain items, such as non-cash gains or losses resulting from mark-to-market adjustments of derivative instruments, among others.
KEURIG DR PEPPER INC. | |||||||
Fourth Quarter | Year Ended December 31, | ||||||
(in millions, except per share data) | 2021 | 2020 | 2021 | 2020 | |||
Net sales | $ 3,391 | $ 3,121 | $ 12,683 | $ 11,618 | |||
Cost of sales | 1,619 | 1,353 | 5,706 | 5,132 | |||
Gross profit | 1,772 | 1,768 | 6,977 | 6,486 | |||
Selling, general and administrative expenses | 1,113 | 1,000 | 4,153 | 3,978 | |||
Impairment of intangible assets | — | 67 | — | 67 | |||
Other operating expense (income), net | (66) | 1 | (70) | (39) | |||
Income from operations | 725 | 700 | 2,894 | 2,480 | |||
Interest expense | 119 | 146 | 500 | 604 | |||
Loss on early extinguishment of debt | — | — | 105 | 4 | |||
Gain on sale of equity method investment | (524) | — | (524) | — | |||
Impairment of investments and note receivable | 17 | — | 17 | 102 | |||
Other expense (income), net | 4 | (4) | (2) | 17 | |||
Income before provision for income taxes | 1,109 | 558 | 2,798 | 1,753 | |||
Provision for income taxes | 266 | 130 | 653 | 428 | |||
Net income including non-controlling interest | 843 | 428 | 2,145 | 1,325 | |||
Less: Net loss attributable to non-controlling interest | — | — | (1) | — | |||
Net income attributable to KDP | $ 843 | $ 428 | $ 2,146 | $ 1,325 | |||
Earnings per common share: | |||||||
Basic | $ 0.59 | $ 0.30 | $ 1.52 | $ 0.94 | |||
Diluted | 0.59 | 0.30 | 1.50 | 0.93 | |||
Weighted average common shares outstanding: | |||||||
Basic | 1,418.0 | 1,407.3 | 1,415.7 | 1,407.2 | |||
Diluted | 1,429.0 | 1,423.8 | 1,427.9 | 1,422.1 |
KEURIG DR PEPPER INC. | |||
December 31, | |||
(in millions, except share and per share data) | 2021 | 2020 | |
Assets | |||
Current assets: | |||
Cash and cash equivalents | $ 567 | $ 240 | |
Restricted cash and restricted cash equivalents | 1 | 15 | |
Trade accounts receivable, net | 1,148 | 1,048 | |
Inventories | 894 | 762 | |
Prepaid expenses and other current assets | 447 | 323 | |
Total current assets | 3,057 | 2,388 | |
Property, plant and equipment, net | 2,494 | 2,212 | |
Investments in unconsolidated affiliates | 30 | 88 | |
Goodwill | 20,182 | 20,184 | |
Other intangible assets, net | 23,856 | 23,968 | |
Other non-current assets | 937 | 894 | |
Deferred tax assets | 42 | 45 | |
Total assets | $ 50,598 | $ 49,779 | |
Liabilities and Stockholders' Equity | |||
Current liabilities: | |||
Accounts payable | $ 4,316 | $ 3,740 | |
Accrued expenses | 1,110 | 1,040 | |
Structured payables | 142 | 153 | |
Short-term borrowings and current portion of long-term obligations | 304 | 2,345 | |
Other current liabilities | 613 | 416 | |
Total current liabilities | 6,485 | 7,694 | |
Long-term obligations | 11,578 | 11,143 | |
Deferred tax liabilities | 5,986 | 5,993 | |
Other non-current liabilities | 1,577 | 1,119 | |
Total liabilities | 25,626 | 25,949 | |
Commitments and contingencies | |||
Stockholders' equity: | |||
Preferred stock, | — | — | |
Common stock, | 14 | 14 | |
Additional paid-in capital | 21,785 | 21,677 | |
Retained earnings | 3,199 | 2,061 | |
Accumulated other comprehensive (income) loss | (26) | 77 | |
Total stockholders' equity | 24,972 | 23,829 | |
Non-controlling interest | — | 1 | |
Total equity | 24,972 | 23,830 | |
Total liabilities and stockholders' equity | $ 50,598 | $ 49,779 |
KEURIG DR PEPPER INC. | |||
Year Ended December 31, | |||
(in millions) | 2021 | 2020 | |
Operating activities: | |||
Net income attributable to KDP | $ 2,146 | $ 1,325 | |
Adjustments to reconcile net income to net cash provided by operating activities: | |||
Depreciation expense | 410 | 362 | |
Amortization of intangibles | 134 | 133 | |
Other amortization expense | 164 | 158 | |
Provision for sales returns | 63 | 54 | |
Deferred income taxes | 31 | (51) | |
Employee stock-based compensation expense | 88 | 85 | |
Loss on early extinguishment of debt | 105 | 4 | |
Gain on sale of equity method investment | (524) | — | |
Gain on disposal of property, plant and equipment | (75) | (36) | |
Unrealized (gain) loss on foreign currency | 9 | (1) | |
Unrealized (gain) loss on derivatives | (70) | 8 | |
Equity in losses of unconsolidated affiliates | 5 | 20 | |
Impairment of intangible assets | — | 67 | |
Impairment on investments and note receivable of unconsolidated affiliates | 17 | 102 | |
Other, net | 20 | 60 | |
Changes in assets and liabilities: | |||
Trade accounts receivable | (152) | (5) | |
Inventories | (133) | (107) | |
Income taxes receivable and payables, net | 114 | (91) | |
Other current and non-current assets | (243) | (435) | |
Accounts payable and accrued expenses | 762 | 624 | |
Other current and non-current liabilities | 3 | 180 | |
Net change in operating assets and liabilities | 351 | 166 | |
Net cash provided by operating activities | 2,874 | 2,456 | |
Investing activities: | |||
Proceeds from sale of investment in unconsolidated affiliates | 578 | — | |
Purchases of property, plant and equipment | (423) | (461) | |
Proceeds from sales of property, plant and equipment | 122 | 203 | |
Purchases of intangibles | (32) | (56) | |
Issuance of related party note receivable | (19) | (6) | |
Investments in unconsolidated affiliates | — | (5) | |
Other, net | (16) | 9 | |
Net cash provided by (used in) investing activities | 210 | (316) | |
Financing activities: | |||
Proceeds from issuance of Notes | 2,150 | 1,500 | |
Repayments of Notes | (3,595) | (250) | |
Proceeds from issuance of commercial paper | 5,406 | 7,288 | |
Repayments of commercial paper | (5,257) | (8,534) | |
Proceeds from KDP Revolver | — | 1,850 | |
Repayments of KDP Revolver | — | (1,850) | |
Repayments of 2019 KDP Term Loan | (425) | (955) | |
Proceeds from structured payables | 156 | 171 | |
Repayments of structured payables | (167) | (341) | |
Cash dividends paid | (955) | (846) | |
Proceeds from issuance of common stock | 140 | — | |
Tax withholdings related to net share settlements | (125) | — | |
Payments on finance leases | (54) | (52) | |
Proceeds from controlling shareholder stock transactions | — | 29 | |
Other, net | (36) | — | |
Net cash used in financing activities | (2,762) | (1,990) | |
Cash, cash equivalents, restricted cash, and restricted cash equivalents: | |||
Net change from operating, investing and financing activities | 322 | 150 | |
Effect of exchange rate changes | (9) | (6) | |
Beginning balance | 255 | 111 | |
Ending balance | $ 568 | $ 255 |
KEURIG DR PEPPER INC. | |||||||
Fourth Quarter | Year Ended December 31, | ||||||
(in millions) | 2021 | 2020 | 2021 | 2020 | |||
Net Sales | |||||||
Coffee Systems | $ 1,318 | $ 1,320 | $ 4,716 | $ 4,433 | |||
Packaged Beverages | 1,530 | 1,307 | 5,882 | 5,363 | |||
Beverage Concentrates | 391 | 358 | 1,486 | 1,325 | |||
Latin America Beverages | 152 | 136 | 599 | 497 | |||
Total net sales | $ 3,391 | $ 3,121 | $ 12,683 | $ 11,618 | |||
Income from Operations | |||||||
Coffee Systems | $ 326 | $ 386 | $ 1,318 | $ 1,268 | |||
Packaged Beverages | 289 | 165 | 1,010 | 822 | |||
Beverage Concentrates | 266 | 253 | 1,044 | 932 | |||
Latin America Beverages | 38 | 32 | 133 | 105 | |||
Unallocated corporate costs | (194) | (136) | (611) | (647) | |||
Total income from operations | $ 725 | $ 700 | $ 2,894 | $ 2,480 |
KEURIG DR PEPPER INC.
RECONCILIATION OF CERTAIN NON-GAAP INFORMATION
(UNAUDITED)
The company reports its financial results in accordance with U.S. GAAP. However, management believes that certain non-GAAP financial measures that reflect the way management evaluates the business may provide investors with additional information regarding the company's results, trends and ongoing performance on a comparable basis.
For the fourth quarter and full year ended December 31, 2021 and 2020, we define our Adjusted non-GAAP financial measures as certain financial statement captions and metrics adjusted for certain items affecting comparability. The items affecting comparability are defined below.
Specifically, investors should consider the following with respect to our financial results:
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results, as well as the unrealized mark-to-market impact of our Vita Coco investment; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense and the associated windfall tax benefit attributable to the matching awards made to employees who made an initial investment in KDP; (vi) non-cash changes in deferred tax liabilities related to goodwill and other intangible assets as a result of tax rate or apportionment changes; and (vii) other certain items that are excluded for comparison purposes to prior year periods.
For the fourth quarter and full year ended December 31, 2021, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) costs related to significant non-routine legal matters; (iv) the loss on early extinguishment of debt related to the redemption of debt; (v) incremental costs to our operations related to risks associated with the COVID-19 pandemic; (vi) gains from insurance recoveries related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment; (vii) the gain on the sale of our investment in BodyArmor; (viii) impairment recognized on our equity method investment with Bedford as a result of funding our share of their wind-down costs; and (ix) transaction costs for significant business combinations (completed or abandoned).
For the fourth quarter and full year ended December 31, 2020, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) transaction costs for significant business combinations (completed or abandoned) excluding the DPS Merger; (iv) costs related to significant non-routine legal matters; (v) the loss on early extinguishment of debt related to the redemption of debt, (vi) incremental costs to our operations related to risks associated with the COVID-19 pandemic and (vii) impairment recognized on our equity method investments with Bedford and LifeFuels.
Costs related to significant non-routine legal matters relate to the antitrust litigation. Incremental costs to our operations related to risks associated with the COVID-19 pandemic include incremental expenses incurred to either maintain the health and safety of our front-line employees or temporarily increase compensation to such employees to ensure essential operations continue during the pandemic.
We believe removing these costs reflects how management views our business results on a consistent basis.
For the fourth quarter and full year ended December 31, 2021 and 2020, the supplemental financial data set forth below includes reconciliations of Adjusted gross margin, Adjusted income from operations, Adjusted operating margin, Adjusted net income and Adjusted diluted EPS to the applicable financial measure presented in the unaudited condensed consolidated financial statement for the same period.
Reconciliations for these items are provided in the tables below.
KEURIG DR PEPPER INC. | ||||||||||||||
Cost of sales | Gross profit | Gross | Selling, general and | Income from | Operating margin | |||||||||
Reported | $ 1,619 | $ 1,772 | 52.3 % | $ 1,113 | $ 725 | 21.4 % | ||||||||
Items Affecting Comparability: | ||||||||||||||
Mark to market | (21) | 21 | (7) | 28 | ||||||||||
Amortization of intangibles | — | — | (33) | 33 | ||||||||||
Stock compensation | — | — | (4) | 4 | ||||||||||
Restructuring and integration costs | — | — | (57) | 57 | ||||||||||
Productivity | (29) | 29 | (19) | 48 | ||||||||||
Non-routine legal matters | — | — | (7) | 7 | ||||||||||
COVID-19 | (4) | 4 | (2) | 6 | ||||||||||
Transaction costs | — | — | (1) | 1 | ||||||||||
Malware incident | — | — | (1) | 1 | ||||||||||
Adjusted | $ 1,565 | $ 1,826 | 53.8 % | $ 982 | $ 910 | 26.8 % |
Interest | Gain on sale | Impairment of | Other | Income before | Provision | Effective | Net income | Diluted | ||||||||||||||||||||||
Reported | $ 119 | $ (524) | $ 17 | $ 4 | $ 1,109 | $ 266 | 24.0 % | $ 843 | $ 0.59 | |||||||||||||||||||||
Items Affecting Comparability: | ||||||||||||||||||||||||||||||
Mark to market | (1) | — | — | (6) | 35 | 10 | 25 | 0.02 | ||||||||||||||||||||||
Amortization of intangibles | — | — | — | — | 33 | 5 | 28 | 0.02 | ||||||||||||||||||||||
Amortization of deferred financing costs | (1) | — | — | — | 1 | — | 1 | — | ||||||||||||||||||||||
Amortization of fair value debt adjustment | (5) | — | — | — | 5 | 2 | 3 | — | ||||||||||||||||||||||
Stock compensation | — | — | — | — | 4 | 1 | 3 | — | ||||||||||||||||||||||
Restructuring and integration costs | — | — | — | — | 57 | 12 | 45 | 0.03 | ||||||||||||||||||||||
Productivity | — | — | — | — | 48 | 11 | 37 | 0.03 | ||||||||||||||||||||||
Impairment of investment | — | — | (17) | — | 17 | (45) | 62 | 0.04 | ||||||||||||||||||||||
Loss on early extinguishment of debt | — | — | — | — | — | — | — | — | ||||||||||||||||||||||
Non-routine legal matters | — | — | — | — | 7 | 2 | 5 | — | ||||||||||||||||||||||
COVID-19 | — | — | — | — | 6 | 1 | 5 | — | ||||||||||||||||||||||
Gain on sale of equity-method investment | — | 524 | — | — | (524) | (124) | (400) | (0.28) | ||||||||||||||||||||||
Transaction costs | — | — | — | — | 1 | — | 1 | — | ||||||||||||||||||||||
Malware incident | — | — | — | — | 1 | 1 | — | — | ||||||||||||||||||||||
Change in deferred tax liabilities related to | — | — | — | — | — | 18 | (18) | (0.01) | ||||||||||||||||||||||
Adjusted | $ 112 | $ — | $ — | $ (2) | $ 800 | $ 160 | 20.0 % | $ 640 | $ 0.45 | |||||||||||||||||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||||||||
Cost of sales | Gross profit | Gross | Selling, general and | Impairment of | Income from | Operating | |||||||
Reported | $ 1,353 | $ 1,768 | 56.6 % | $ 1,000 | $ 67 | $ 700 | 22.4 % | ||||||
Items Affecting Comparability: | |||||||||||||
Mark to market | 31 | (31) | 23 | — | (54) | ||||||||
Amortization of intangibles | — | — | (33) | — | 33 | ||||||||
Stock compensation | — | — | (6) | — | 6 | ||||||||
Restructuring and integration costs | — | — | (56) | — | 56 | ||||||||
Productivity | (1) | 1 | (24) | — | 25 | ||||||||
Impairment on intangible asset | — | — | — | (67) | 67 | ||||||||
Non-routine legal matters | — | — | (14) | — | 14 | ||||||||
COVID-19 | (6) | 6 | (5) | — | 11 | ||||||||
Adjusted | $ 1,377 | $ 1,744 | 55.9 % | $ 885 | $ — | $ 858 | 27.5 % |
Interest | Income before provision for | Provision for | Effective tax | Net income | Diluted earnings per | ||||||||
Reported | $ 146 | $ 558 | $ 130 | 23.3 % | $ 428 | $ 0.30 | |||||||
Items Affecting Comparability: | |||||||||||||
Mark to market | 1 | (55) | (14) | (41) | (0.03) | ||||||||
Amortization of intangibles | — | 33 | 8 | 25 | 0.02 | ||||||||
Amortization of deferred financing costs | (3) | 3 | 1 | 2 | — | ||||||||
Amortization of fair value debt adjustment | (6) | 6 | 2 | 4 | — | ||||||||
Stock compensation | — | 6 | 1 | 5 | — | ||||||||
Restructuring and integration costs | — | 56 | 15 | 41 | 0.03 | ||||||||
Productivity | — | 25 | 6 | 19 | 0.01 | ||||||||
Impairment on intangible asset | — | 67 | 15 | 52 | 0.04 | ||||||||
Non-routine legal matters | — | 14 | 4 | 10 | 0.01 | ||||||||
COVID-19 | — | 11 | 2 | 9 | 0.01 | ||||||||
Adjusted | $ 138 | $ 724 | $ 170 | 23.5 % | $ 554 | $ 0.39 | |||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | ||||||||||||||
Cost of sales | Gross profit | Gross | Selling, general and | Income from | Operating | |||||||||
Reported | $ 5,706 | $ 6,977 | 55.0 % | $ 4,153 | $ 2,894 | 22.8 % | ||||||||
Items Affecting Comparability: | ||||||||||||||
Mark to market | 32 | (32) | 25 | (57) | ||||||||||
Amortization of intangibles | — | — | (134) | 134 | ||||||||||
Stock compensation | — | — | (18) | 18 | ||||||||||
Restructuring and integration costs | — | — | (202) | 202 | ||||||||||
Productivity | (72) | 72 | (91) | 163 | ||||||||||
Non-routine legal matters | — | — | (30) | 30 | ||||||||||
COVID-19 | (26) | 26 | (11) | 37 | ||||||||||
Transaction costs | — | — | (2) | 2 | ||||||||||
Malware incident | — | — | 2 | (2) | ||||||||||
Adjusted | $ 5,640 | $ 7,043 | 55.5 % | $ 3,692 | $ 3,421 | 27.0 % |
Interest | Loss on early | Impairment of | Gain on sale | Other | Income | Provision | Effective | Net income | Diluted | ||||||||||
Reported | $ 500 | $ 105 | $ 17 | $ (524) | $ (2) | $ 2,798 | $ 653 | 23.3 % | $ 2,146 | $ 1.50 | |||||||||
Items Affecting Comparability: | |||||||||||||||||||
Mark to market | 6 | — | — | — | (6) | (57) | (13) | (44) | (0.03) | ||||||||||
Amortization of intangibles | — | — | — | — | — | 134 | 31 | 103 | 0.07 | ||||||||||
Amortization of deferred financing costs | (7) | — | — | — | — | 7 | 2 | 5 | — | ||||||||||
Amortization of fair value debt adjustment | (19) | — | — | — | — | 19 | 5 | 14 | 0.01 | ||||||||||
Stock compensation | — | — | — | — | — | 18 | 15 | 3 | — | ||||||||||
Restructuring and integration costs | — | — | — | — | — | 202 | 47 | 155 | 0.11 | ||||||||||
Productivity | — | — | — | — | — | 163 | 40 | 123 | 0.09 | ||||||||||
Impairment of investment | — | — | (17) | — | — | 17 | (45) | 62 | 0.04 | ||||||||||
Loss on early extinguishment of debt | — | (105) | — | — | — | 105 | 24 | 81 | 0.06 | ||||||||||
Non-routine legal matters | — | — | — | — | — | 30 | 7 | 23 | 0.02 | ||||||||||
COVID-19 | — | — | — | — | — | 37 | 9 | 28 | 0.02 | ||||||||||
Gain on sale of equity-method investment | — | — | — | 524 | — | (524) | (124) | (400) | (0.28) | ||||||||||
Transaction costs | — | — | — | — | — | 2 | — | 2 | — | ||||||||||
Malware incident | — | — | — | — | — | (2) | — | (2) | — | ||||||||||
Change in deferred tax liabilities related to | — | — | — | — | — | — | 19 | (19) | (0.01) | ||||||||||
Adjusted | $ 480 | $ — | $ — | $ — | $ (8) | $ 2,949 | $ 670 | 22.7 % | $ 2,280 | $ 1.60 | |||||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||||||||||
Cost of sales | Gross profit | Gross | Selling, general and | Impairment of | Income from | Operating | |||||||
Reported | $ 5,132 | $ 6,486 | 55.8 % | $ 3,978 | $ 67 | $ 2,480 | 21.3 % | ||||||
Items Affecting Comparability: | |||||||||||||
Mark to market | 33 | (33) | (5) | — | (28) | ||||||||
Amortization of intangibles | — | — | (133) | — | 133 | ||||||||
Stock compensation | — | — | (27) | — | 27 | ||||||||
Restructuring and integration costs | — | — | (199) | — | 199 | ||||||||
Productivity | (29) | 29 | (99) | — | 128 | ||||||||
Impairment on intangible asset | — | — | — | (67) | 67 | ||||||||
Non-routine legal matters | — | — | (57) | — | 57 | ||||||||
COVID-19 | (44) | 44 | (84) | — | 128 | ||||||||
Adjusted | $ 5,092 | $ 6,526 | 56.2 % | $ 3,374 | $ — | $ 3,191 | 27.5 % |
Interest | Loss on early | Impairment of | Income before | Provision | Effective | Net income | Diluted | ||||||||
Reported | $ 604 | $ 4 | $ 102 | $ 1,753 | $ 428 | 24.4 % | $ 1,325 | $ 0.93 | |||||||
Items Affecting Comparability: | |||||||||||||||
Mark to market | (27) | — | — | (1) | (1) | — | — | ||||||||
Amortization of intangibles | — | — | — | 133 | 35 | 98 | 0.07 | ||||||||
Amortization of deferred financing costs | (11) | — | — | 11 | 3 | 8 | 0.01 | ||||||||
Amortization of fair value debt adjustment | (24) | — | — | 24 | 6 | 18 | 0.01 | ||||||||
Stock compensation | — | — | — | 27 | 5 | 22 | 0.02 | ||||||||
Restructuring and integration costs | — | — | — | 199 | 49 | 150 | 0.11 | ||||||||
Productivity | — | — | — | 128 | 33 | 95 | 0.07 | ||||||||
Impairment on intangible asset | — | — | — | 67 | 15 | 52 | 0.04 | ||||||||
Loss on early extinguishment of debt | — | (4) | — | 4 | 1 | 3 | — | ||||||||
Impairment of investment | — | — | (102) | 102 | 25 | 77 | 0.05 | ||||||||
Non-routine legal matters | — | — | — | 57 | 14 | 43 | 0.03 | ||||||||
COVID-19 | — | — | — | 128 | 31 | 97 | 0.07 | ||||||||
Adjusted | $ 542 | $ — | $ — | $ 2,632 | $ 644 | 24.5 % | $ 1,988 | $ 1.40 | |||||||
Diluted earnings per common share may not foot due to rounding. |
KEURIG DR PEPPER INC. | |||||
(in millions) | Reported | Items Affecting | Adjusted | ||
For the fourth quarter of 2021 | |||||
Income from Operations | |||||
Coffee Systems | $ 326 | $ 52 | $ 378 | ||
Packaged Beverages | 289 | 25 | 314 | ||
Beverage Concentrates | 266 | 5 | 271 | ||
Latin America Beverages | 38 | — | 38 | ||
Unallocated corporate costs | (194) | 103 | (91) | ||
Total income from operations | $ 725 | $ 185 | $ 910 | ||
For the fourth quarter of 2020 | |||||
Income from Operations | |||||
Coffee Systems | $ 386 | $ 45 | $ 431 | ||
Packaged Beverages | 165 | 80 | 245 | ||
Beverage Concentrates | 253 | 1 | 254 | ||
Latin America Beverages | 32 | 1 | 33 | ||
Unallocated corporate costs | (136) | 31 | (105) | ||
Total income from operations | $ 700 | $ 158 | $ 858 |
KEURIG DR PEPPER INC. | |||||
(in millions) | Reported | Items | Adjusted | ||
For the year ended December 31, 2021 | |||||
Income from Operations | |||||
Coffee Systems | $ 1,318 | $ 197 | $ 1,515 | ||
Packaged Beverages | 1,010 | 99 | 1,109 | ||
Beverage Concentrates | 1,044 | 11 | 1,055 | ||
Latin America Beverages | 133 | 2 | 135 | ||
Unallocated corporate costs | (611) | 218 | (393) | ||
Total income from operations | $ 2,894 | $ 527 | $ 3,421 | ||
For the year ended December 31, 2020 | |||||
Income from Operations | |||||
Coffee Systems | $ 1,268 | $ 246 | $ 1,514 | ||
Packaged Beverages | 822 | 199 | 1,021 | ||
Beverage Concentrates | 932 | 6 | 938 | ||
Latin America Beverages | 105 | 3 | 108 | ||
Unallocated corporate costs | (647) | 257 | (390) | ||
Total income from operations | $ 2,480 | $ 711 | $ 3,191 |
KEURIG DR PEPPER INC. | |
(in millions, except for ratio) | |
ADJUSTED EBITDA RECONCILIATION - LAST TWELVE MONTHS | |
Net income attributable to KDP | $ 2,146 |
Interest expense | 500 |
Provision for income taxes | 653 |
Other (income) expense, net | (2) |
Depreciation expense | 410 |
Other amortization | 164 |
Amortization of intangibles | 134 |
EBITDA | $ 4,005 |
Items affecting comparability: | |
Gain on sale of equity-method investment | $ (524) |
Loss on early extinguishment of debt | 105 |
Impairment of investments and note receivable | 17 |
Restructuring and integration expenses | 202 |
Productivity | 138 |
Non-routine legal matters | 30 |
Stock compensation | 18 |
COVID-19 | 37 |
Transaction costs | 2 |
Malware incident | (2) |
Mark to market | (57) |
Adjusted EBITDA | $ 3,971 |
December 31, | |
2021 | |
Principal amounts of: | |
Commercial paper notes | $ 149 |
Senior unsecured notes | 11,875 |
Total principal amounts | 12,024 |
Less: Cash and cash equivalents | 567 |
Total principal amounts less cash and cash equivalents | $ 11,457 |
December 31, 2021 Management Leverage Ratio | 2.9 |
KEURIG DR PEPPER INC.
RECONCILIATION OF NET CASH PROVIDED BY OPERATING ACTIVITIES TO FREE CASH FLOW
(Unaudited)
Free cash flow is defined as net cash provided by operating activities adjusted for purchases of property, plant and equipment, proceeds from sales of property, plant and equipment, and certain items excluded for comparison to prior year periods. For the years ended December 31, 2020 and 2019, there were no certain items excluded for comparison to prior year periods.
Year Ended December 31, | ||||
(in millions) | 2021 | 2020 | ||
Net cash provided by operating activities | $ 2,874 | $ 2,456 | ||
Purchases of property, plant and equipment | (423) | (461) | ||
Proceeds from sales of property, plant and equipment | 122 | 203 | ||
Free Cash Flow | $ 2,573 | $ 2,198 |
RECONCILIATION OF CERTAIN CURRENCY NEUTRAL ADJUSTED FINANCIAL RESULTS
(Unaudited)
Net sales, adjusted income from operations and adjusted earnings per share, as adjusted to currency neutral: These adjusted financial results are calculated on a currency neutral basis by converting our current-period local currency financial results using the prior-period foreign currency exchange rates.
Coffee | Packaged | Beverage | Latin | Total | ||||||
For the fourth quarter of 2021 | ||||||||||
Net sales | (0.2)% | |||||||||
Impact of foreign currency | (0.3)% | (0.1)% | (0.3)% | (0.2)% | ||||||
Net sales, as adjusted to currency neutral | (0.5)% | |||||||||
For the year ended December 31, 2021 | ||||||||||
Net sales | ||||||||||
Impact of foreign currency | (0.8)% | (0.2)% | (0.5)% | (6.4)% | (0.8)% | |||||
Net sales, as adjusted to currency neutral |
Coffee | Packaged | Beverage | Latin | Total | ||||||
For the fourth quarter of 2021 | ||||||||||
Adjusted income from operations | (12.3)% | |||||||||
Impact of foreign currency | —% | (0.4)% | (0.4)% | (0.2)% | ||||||
Adjusted income from operations, as adjusted | (12.3)% | |||||||||
For the year ended December 31, 2021 | ||||||||||
Adjusted income from operations | ||||||||||
Impact of foreign currency | (0.5)% | (0.3)% | (0.6)% | (5.6)% | (0.7)% | |||||
Adjusted income from operations, as adjusted | (0.4)% |
Fourth Quarter of | Year Ended December 31, | |||
Adjusted diluted earnings per share | $ 0.45 | $ 1.60 | ||
Impact of foreign currency | — | (0.01) | ||
Adjusted diluted earnings per share, as adjusted to currency neutral | $ 0.45 | $ 1.59 |
The following table sets forth our reconciliation of significant COVID-19-related expenses. However, employee compensation expense and employee protection costs, which impact our SG&A expenses and cost of sales, are included as the COVID-19 item affecting comparability and are excluded in our Adjusted financial measures. In addition, reported amounts under U.S. GAAP also include additional costs, not included as the COVID-19 item affecting comparability, as presented in tables below.
Items Affecting Comparability(1) | |||||||||
(in millions) | Employee | Employee | Allowances | Inventory | Total | ||||
For the fourth quarter of 2021 | |||||||||
Coffee Systems | $ 1 | $ 2 | $ — | $ — | $ 3 | ||||
Packaged Beverages | 1 | 1 | — | — | 2 | ||||
Beverage Concentrates | — | — | — | — | — | ||||
Latin America Beverages | — | 1 | — | — | 1 | ||||
Total | $ 2 | $ 4 | $ — | $ — | $ 6 | ||||
For the fourth quarter of 2020 | |||||||||
Coffee Systems | $ 1 | $ 3 | $ — | $ — | $ 4 | ||||
Packaged Beverages | 3 | 3 | — | — | 6 | ||||
Beverage Concentrates | — | — | — | — | — | ||||
Latin America Beverages | — | 1 | — | — | 1 | ||||
Total | $ 4 | $ 7 | $ — | $ — | $ 11 | ||||
For the year ended December 31, | |||||||||
Coffee Systems | $ 4 | $ 16 | $ (2) | $ — | $ 18 | ||||
Packaged Beverages | 8 | 7 | (8) | — | 7 | ||||
Beverage Concentrates | — | — | (3) | — | (3) | ||||
Latin America Beverages | — | 2 | — | — | 2 | ||||
Total | $ 12 | $ 25 | $ (13) | $ — | $ 24 | ||||
For the year ended December 31, | |||||||||
Coffee Systems | $ 15 | $ 10 | $ 2 | $ 8 | $ 35 | ||||
Packaged Beverages | 76 | 25 | 8 | — | 109 | ||||
Beverage Concentrates | — | — | 4 | — | 4 | ||||
Latin America Beverages | — | 2 | — | — | 2 | ||||
Total | $ 91 | $ 37 | $ 14 | $ 8 | $ 150 | ||||
(1) | Employee compensation expense and employee protection costs are both included as the COVID-19 items affecting comparability in the reconciliation of our Adjusted Non-GAAP financial measures. |
(2) | In 2021, primarily included incremental benefits provided to frontline workers such as extended sick leave, in order to maintain essential operations during the COVID-19 pandemic. In 2020, primarily reflected temporary incremental frontline incentive pay and benefits, as well as pay for temporary employees, including the associated taxes. Impacts both cost of sales and SG&A expenses. |
(3) | Included costs associated with personal protective equipment, temperature scans, cleaning and other sanitization services. Impacts both cost of sales and SG&A expenses. |
(4) | In 2020, allowances reflected the expected impact of the economic uncertainty caused by COVID-19, leveraging estimates of credit worthiness, default and recovery rates for certain of our customers. In 2021, reversals of those allowances reflect improving economic conditions. Impacts SG&A expenses. |
(5) | Impacts cost of sales. |
RECONCILIATION OF CERTAIN ADJUSTED FINANCIAL RESULTS
FOR THE YEAR ENDED DECEMBER 31, 2019
(Unaudited, in millions, except per share data)
For the purposes of additional analysis, we have also included certain non-GAAP financial measures for the year ended December 31, 2019.
For the year ended December 31, 2019, we define our Adjusted non-GAAP financial measures as certain financial statement captions and metrics adjusted for certain items affecting comparability. The items affecting comparability are defined below.
Adjusted: Defined as certain financial statement captions and metrics adjusted for certain items affecting comparability.
Items affecting comparability: Defined as certain items that are excluded for comparison to prior year periods, adjusted for the tax impact as applicable. Tax impact is determined based upon an approximate rate for each item. For each period, management adjusts for (i) the unrealized mark-to-market impact of derivative instruments not designated as hedges in accordance with U.S. GAAP and do not have an offsetting risk reflected within the financial results; (ii) the amortization associated with definite-lived intangible assets; (iii) the amortization of the deferred financing costs associated with the DPS Merger; (iv) the amortization of the fair value adjustment of the senior unsecured notes obtained as a result of the DPS Merger; (v) stock compensation expense and the associated windfall tax benefit attributable to the matching awards made to employees who made an initial investment in KDP; and (vi) other certain items that are excluded for comparison purposes to prior year periods.
For the year ended December 31, 2019, the other certain items excluded for comparison purposes include (i) restructuring and integration expenses related to significant business combinations; (ii) productivity expenses; (iii) transaction costs for significant business combinations (completed or abandoned) not associated with the DPS Merger; (iv) costs related to significant non-routine legal matters; (v) the impact of the step-up of acquired inventory not associated with the DPS Merger (vi) the loss on early extinguishment of debt related to the redemption of debt; and (vii) the loss related to the February 2019 organized malware attack on our business operation networks in the Coffee Systems segment.
Net Sales | Income from operations | Diluted earnings per share | ||||
Reported | $ 11,120 | $ 2,378 | $ 0.88 | |||
Items Affecting Comparability: | ||||||
Mark to market | — | (45) | — | |||
Amortization of intangibles | — | 126 | 0.06 | |||
Amortization of deferred financing costs | — | — | 0.01 | |||
Amortization of fair value debt adjustment | — | — | 0.01 | |||
Stock compensation | — | 24 | 0.01 | |||
Restructuring and integration costs | — | 242 | 0.13 | |||
Productivity | — | 97 | 0.05 | |||
Transaction costs | — | 9 | 0.01 | |||
Inventory step-up | — | 3 | — | |||
Loss on early extinguishment of debt | — | — | 0.01 | |||
Nonroutine legal matters | — | 48 | 0.02 | |||
Malware incident | — | 8 | — | |||
Adjusted | $ 11,120 | $ 2,890 | $ 1.22 | |||
Diluted earnings per common share may not foot due to rounding. |
RECONCILIATION OF CURRENCY NEUTRAL FINANCIAL RESULTS
FOR THE YEAR ENDED DECEMBER 31, 2021 COMPARED TO THE YEAR ENDED DECEMBER 31, 2019
(Unaudited)
Net sales as adjusted to currency neutral: This adjusted financial result is calculated on a currency neutral basis by converting our local currency net sales for the year ended December 31, 2021 using the foreign currency exchange rates from the year ended December 31, 2019.
Growth (%) | ||
Net sales growth compared to the year ended December 31, 2019 | ||
Impact of foreign currency | (0.2)% | |
Net sales growth compared to the year ended December 31, 2019, as adjusted to currency neutral |
View original content to download multimedia:https://www.prnewswire.com/news-releases/keurig-dr-pepper-reports-full-year-2021-results-and-successful-delivery-of-three-year-merger-commitments-301489482.html
SOURCE Keurig Dr Pepper Inc.